Literature DB >> 15465394

Impact of Parkinson's disease on patients' adolescent and adult children.

Anette Schrag1, David Morley, Niall Quinn, Marjan Jahanshahi.   

Abstract

We assessed the impact of Parkinson's disease (PD) on the well-being of patients' adolescent and adult children. Eighty-nine participants aged 12-48 completed a number of questionnaires on quality of life (QoL) and psychosocial variables. One fifth of the participants were mildly to moderately depressed, and children below the age of 18 years scored similarly to children with epilepsy in the domains of Attitude, School behaviour, and Social support on a QoL instrument for children with epilepsy. The impact of parental PD increased with disease duration. Younger children perceived a higher burden of daily help and impact on their social interactions than older children, while older participants reported greater impairment of family functioning. More than 50% felt that they did not have sufficient information about PD and half of all participants felt that more information would reduce their feelings of uncertainty and insecurity. PD has a marked effect on the well-being of the adult and adolescent children of patients. The difficulties of children of parents with PD should receive greater attention.

Entities:  

Mesh:

Year:  2004        PMID: 15465394     DOI: 10.1016/j.parkreldis.2004.03.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

1.  Problem behavior in children of chronically ill parents: a meta-analysis.

Authors:  D S Sieh; A M Meijer; F J Oort; J M A Visser-Meily; D A V Van der Leij
Journal:  Clin Child Fam Psychol Rev       Date:  2010-12

2.  Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease.

Authors:  Paul Ardayfio; Jisook Moon; Ka Ka Amanda Leung; Dong Youn-Hwang; Kwang-Soo Kim
Journal:  Neurobiol Dis       Date:  2008-06-04       Impact factor: 5.996

3.  Parkinson's disease permanent care unit: managing the chronic-palliative interface.

Authors:  Johan Lökk
Journal:  J Multidiscip Healthc       Date:  2011-04-01

4.  Adolescent and adult children of parents with Parkinson's disease: incorporating their needs in clinical guidelines.

Authors:  David Morley; Caroline Selai; Anette Schrag; Marjan Jahanshahi; Alan Thompson
Journal:  Parkinsons Dis       Date:  2011-06-12

5.  Furthering our understanding of the needs of adolescent children of parents with Parkinson's disease.

Authors:  David Morley; Crispin Jenkinson
Journal:  Adolesc Health Med Ther       Date:  2013-07-29

6.  Associations among Cognitive Functions, Plasma DNA, and White Matter Integrity in Patients with Early-Onset Parkinson's Disease.

Authors:  Yueh-Sheng Chen; Meng-Hsiang Chen; Cheng-Hsien Lu; Pei-Chin Chen; Hsiu-Ling Chen; I-Hsiao Yang; Nai-Wen Tsai; Wei-Che Lin
Journal:  Front Neurosci       Date:  2017-01-24       Impact factor: 4.677

Review 7.  Young People's Response to Parental Neurological Disorder: A Structured Review.

Authors:  Lilian Hartman; Crispin Jenkinson; David Morley
Journal:  Adolesc Health Med Ther       Date:  2020-03-26

Review 8.  Effects of Parkinson's on employment, cost of care, and quality of life of people with condition and family caregivers in the UK: a systematic literature review.

Authors:  Anil Gumber; Bhanu Ramaswamy; Oranuch Thongchundee
Journal:  Patient Relat Outcome Meas       Date:  2019-10-21

9.  Parkinson's Symptoms and Caregiver Burden and Mental Health: A Cross-Cultural Mediational Model.

Authors:  Erin R Smith; Paul B Perrin; Carmen M Tyler; Sarah K Lageman; Teresita Villaseñor
Journal:  Behav Neurol       Date:  2019-12-01       Impact factor: 3.342

10.  Health-related quality of life, depression, and self-esteem in adolescents with leprosy-affected parents: results of a cross-sectional study in Nepal.

Authors:  Nobuko Yamaguchi; Krishna C Poudel; Masamine Jimba
Journal:  BMC Public Health       Date:  2013-01-10       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.